Compile Data Set for Download or QSAR
maximum 50k data
Found 5 Enz. Inhib. hit(s) with Target = 'Cannabinoid receptor 2' and Ligand = 'BDBM242431'
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  19nM ΔG°:  -44.8kJ/mole IC50:  37nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  29nM ΔG°:  -43.7kJ/mole IC50:  56nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  29.2nM ΔG°:  -43.7kJ/mole IC50:  58.1nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  34nM ΔG°:  -43.3kJ/mole IC50:  76nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  37nM ΔG°:  -43.1kJ/mole IC50:  68nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent